It promotes healing. It promotes all the kinds of things that must happen in a wound or in your damaged gum that make wounds heal. And a great deal of that, by the way, depends on blood supply. Nothing will heal without what's called microcirculation. And NCT is a great stimulator of microcirculation.

 

Tissues get a nice supply of capillary blood supply and it also shuts down the most harmful pieces of inflammation. It sort of puts oil on the water of inflammation and promotes the changes in your tissues that make you heal. 

 

And we think that that's really one of the great benefits of HOCl is its capacity to leave a big footprint. It leaves behind a modification of taurine, converts it to NCT, and that NCT is not lightning fast. It's slow and it's steady. 

 

It's anti-inflammatory. It stimulates new blood vessel formation. If it's in a wound on your skin, it stimulates the closure of the skin, the movement of your skin cells to close over the site. It does all those good things and those are all measurable. 

 

They're all published so scientific literature supports that all those are measurable changes come about from HOCl  and when we apply external supplies of HOCl  when we use it as a wound irrigant or as a mouth rinse, we get all those benefits stimulated by the reaction of HOCl  with the amino acid taurine.

 

-- Jeffrey F. Williams, PhD, BVSc, MRCVS, microbiologist and infectious disease expert, has devoted his career to researching, inventing and bringing to market solutions that have improved the lives and health of people all over the world. 

 

-- Professor of Microbiology and Molecular Genetics, Michigan State University (Emeritus)

 

-- Elected Fellow of the American Association for the Advancement of Science (AAAS)

 

-- Holder of 30+ patents covering water treatment, disease control, odor control

 

-- Author of 200+ scientific papers and textbook chapters

 

-- Member of the Board of Counselors, National Institute of Allergy and Infectious Diseases, National Institute of Health (1984-88)

 

-- ​Chairman of a World Health Organization research committee on tropical diseases (based in Geneva) (1985-1989)

 

-- Chief Science Officer, HOCL producer that is world leader in hypochlorous acid technology and manufacturing (2014-2024)